Qatar-based Aspetar signs collaboration deal with HMC’s Heart Hospital

By Shilpa Annie Joseph, Official Reporter
  • Follow author on
Representational Image

Qatar’s premier not-for-profit healthcare provider, Hamad Medical Corporation’s (HMC) Heart Hospital (HH) has signed an agreement with the leading specialised orthopaedic and sports medicine hospital, Aspetar in order to establish an Aspetar-HMC Clinical Specialist Fellowship in Sports Cardiology Program.

As per the reports, the program is aimed at developing future medical expertise in sports cardiology to benefit patients and athletes in the Qatar region.

Sports cardiology is a vital and rapidly expanding subspecialty of cardiology that focuses on the cardiovascular care of athletes and active individuals.

Dr. Abdulaziz Al Kuwari
Dr. Abdulaziz Al Kuwari
CEO – Aspetar

“The fellowship program provides exciting opportunities for young cardiologists to pursue a career in sports cardiology. As an internationally accredited teaching organization, we place great emphasis on the development of high-quality medical education programs that will develop highly qualified and competent physicians to provide excellent clinical care and engage in associated research. This partnership agreement with Aspetar will provide a new avenue for those cardiology specialists who are interested in this burgeoning medical field.”

The Heart Hospital Medical Director, Dr. Nidal Asaad, noted that the strengths of both organizations will be used to serve patients, athletes, and clinicians alike.

“The Heart Hospital is an excellent facility that has a strong cardiology faculty who are experienced in training highly qualified cardiologists. By collaborating with the longstanding Sports Cardiology Fellowship Program, we benefit from their experience in sports cardiology as well as having valuable access to Aspetar’s state-of-the-art facility and equipment. Together we can provide a unique opportunity for future clinical specialist fellows in sports cardiology to gain further clinical experience,” Dr. Assad added.

Related: UAE’s In5 Incubator welcomes emerging US Bio-tech firm InSitu Biologics